A cancer-detecting breathalyzer has moved into clinical trials
1500 participants are need for the trials. Image: REUTERS/Stefan Wermuth
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Healthcare Delivery
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Healthcare DeliverySee all
Dr Ibironke Dada, Dr Emmanuella Zamba and Drs Aafke de Graaff
September 18, 2023
Shyam Bishen
September 13, 2023
Yoshinobu Nagamine and Toby Norman
September 12, 2023
Elmer Aluge
September 6, 2023
Bill Gates
September 5, 2023
August 31, 2023